📊 Definition & incidence
Hydrops = ≥2 abnormal fluid collections (ascites, pleural/pericardial effusion, skin edema >5mm). Nonimmune causes 85-90%. Incidence 1:1,700-4,000 pregnancies.
🧬 Etiologies (broad)
Cardiovascular (21%): structural defects, arrhythmias, cardiomyopathies. Chromosomal (15%): Turner, trisomies. Lymphatic: thoracic duct atresia, chylothorax. Hematologic (10%): α-thalassemia, parvovirus B19, fetomaternal hemorrhage.
🦠 Infectious (6.7%)
Parvovirus B19 (most common infectious cause), CMV, syphilis, toxoplasmosis, coxsackievirus.
⚕️ Prenatal evaluation
Fetal US/MRI, echocardiography, MCA Doppler (anemia), amniocentesis (karyotype, microarray, infection PCR), Kleihauer-Betke (fetomaternal hemorrhage).
🩺 Postnatal management
Delivery at tertiary center. Immediate respiratory support (may need thoracentesis/paracentesis), treat underlying cause (transfusion for anemia, antiarrhythmics for SVT). Lymphatic disorders: octreotide, surgical intervention.
📈 Prognosis
Mortality ~50%. Better outcomes with parvo B19, isolated chylothorax, or SVT. Poor prognosis with chromosomal aneuploidies, severe structural heart disease, or hydrops at early GA.